Nexalin Technology Reports Results of Clinical Study Support

New migraine data builds on prior clinical studies in depressionHOUSTON, Aug. 07, 2023 -- Nexalin Technology, Inc. today provided an update on the growing body of clinical data supporting the...

Related Keywords

United States , Houston , Texas , China , Zhengzhou , Henan , Nexalin Gen , Mark White , Chinj Neuromed , Exchange Commission , Nexalin Technology Inc , Nexalin Technology , Wider Come Limited , United States Department Of Health , Company Or Nexalin Nasdaq , Vertigo Center , World Health Organization , Company Report On Form , Second Affiliated Hospital Of Zhengzhou University , Crescendo Communications , Company Gen , National Medical Products Administration , Department Of Neurology , Human Services , Second Affiliated Hospital , Visual Analog Scale , Pittsburgh Sleep Quality Index , Hamilton Anxiety Rating Scale , Hamilton Depression Rating Scale , Migraine Specific Quality , Life Questionnaire , United States Department , Risk Factors , Markets ,